Bacteriophage and composition comprising same

US10286020B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10286020-B2
Application numberUS-201515304414-A
CountryUS
Kind codeB2
Filing dateApr 14, 2015
Priority dateApr 15, 2014
Publication dateMay 14, 2019
Grant dateMay 14, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a novel bacteriophage ΦCJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ΦCJ24 (KCCM11462P) or the composition.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for treating infectious diseases caused by avian pathogenic Escherichia coli, comprising: administering the bacteriophage ΦCJ24 (Accession No. KCCM11462P) to birds. 2. The method for preventing or treating infectious diseases caused by avian pathogenic Escherichia coli according to claim 1 , wherein the infectious disease is avian colibacillosis. 3. A method for treating infectious diseases caused by avian pathogenic Escherichia coli, comprising: administering a composition comprising the bacteriophage ΦCJ24 (Accession No. KCCM11462P) to birds.

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • of live microorganisms · CPC title

  • for poultry · CPC title

  • Nucleic acids; Hydrolysis products or derivatives thereof · CPC title

  • A61K35/76Primary

    Viruses; Subviral particles; Bacteriophages · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10286020B2 cover?
The present invention relates to a novel bacteriophage ΦCJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ΦCJ24 (KCCM11462P) or the composition.
Who is the assignee on this patent?
Cj Cheiljedang Corp
What technology area does this patent fall under?
Primary CPC classification A61K35/76. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).